BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15731166)

  • 1. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.
    Hou L; Chatterjee N; Huang WY; Baccarelli A; Yadavalli S; Yeager M; Bresalier RS; Chanock SJ; Caporaso NE; Ji BT; Weissfeld JL; Hayes RB
    Carcinogenesis; 2005 Jun; 26(6):1122-8. PubMed ID: 15731166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
    Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
    Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas.
    Inoue H; Kiyohara C; Marugame T; Shinomiya S; Tsuji E; Handa K; Hayabuchi H; Onuma K; Hamada H; Koga H; Kono S
    Cancer Res; 2000 Jul; 60(14):3749-52. PubMed ID: 10919645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
    Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
    World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
    Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
    Yang M; Choi Y; Hwangbo B; Lee JS
    Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors.
    Schwartzbaum JA; Ahlbom A; Lönn S; Warholm M; Rannug A; Auvinen A; Christensen HC; Henriksson R; Johansen C; Lindholm C; Malmer B; Salminen T; Schoemaker MJ; Swerdlow AJ; Feychting M
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):559-65. PubMed ID: 17372252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
    Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
    BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
    Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between a NQO1 genetic polymorphism and risk of lung cancer.
    Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
    Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
    Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis.
    Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL
    Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627
    [No Abstract]   [Full Text] [Related]  

  • 19. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.